You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Embolism and thrombosis

Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults

  • Technology appraisal guidance
  • Reference number: TA170
  • Published:  22 April 2009
  • Guidance
  • Tools and resources
  • Information for the public
  • History
Download guidance (PDF)
  • Overview
  • 1 Recommendations
  • 2 The technology
  • 3 The manufacturer's submission
  • 4 Consideration of the evidence
  • 5 Implementation
  • 6 Recommendations for further research
  • 7 Appraisal Committee members, guideline representatives and NICE project team
  • 8 Sources of evidence considered by the Committee
  • Update information

Update information

Minor changes since publication

February 2014: Implementation section updated to clarify that rivaroxaban is recommended as an option for preventing venous thromboembolism after total hip or total knee replacement in adults.

ISBN: 978-1-4731-6520-5


Previous page 8 Sources of evidence considered by the Committee
Back to top